IFNA1 and systemic lupus erythematosus: Type I interferon (IFN-I) has been suggested to play a key role in SLE pathogenesis and IFN delivered exogenously with an adenovirus encoding IFNα (Adv-IFNα) or stimulated by poly (I:C), has been used to accelerate disease in lupus prone mice [4–7].